Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$150,000.00
May 1, 2017
Therapy development for pediatric diseases by gene correction in vivo
$105,000.00
May 1, 2017
Biofeedback-enhanced movement-based video game therapy for children with cerebral palsy
$105,000.00
May 1, 2017
Comparing Self-reported and Rater-assessed Clinician Fidelity to Cognitive Processing Therapy for Posttraumatic Stress Disorder
$150,000.00
May 1, 2017
Function of PAI-1 and regulation of its gene expression in human diabetic platelets
$105,000.00
May 1, 2017
Preclinical imaging platform for assessing a novel anti-amyloid therapy
$105,000.00
May 1, 2017
Development of oral child-friendly formulations for the maintenance therapy in childhood acute lymphoblastic leukemia
$350,000.00
May 1, 2017
For-profit organization
Development of a biologic for the treatment of diabetic macular edema
885836
A novel treatment that will offer a new alternative to poor responders of currrent therapies of diabetic macular edema.
$349,500.00
Apr 25, 2017
Wireless neurophotonic probes for the interrogation of neurons in memory circuits
CHRPJ
$194,419.00
Apr 25, 2017
Real-time Breast Cancer Surgery Navigation
CHRPJ
$248,750.00
Apr 25, 2017
Development of antibody-drug conjugates that use actin-targeting warheads
CHRPJ